EVALUATION OF THE EFFICACY OF AMNIOTIC CHORION MEMBRANE IN MANAGEMENT OF GRADE II FURCATION DEFECTS (CLINICAL STUDY) | ||
| Alexandria Dental Journal | ||
| Article 17, Volume 43, Issue 3, December 2018, Pages 102-108 PDF (544.87 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/adjalexu.2018.58007 | ||
| Authors | ||
| Raneem M. Gamal1; Mona Lotfy2; Maha Taalab3 | ||
| 1- BDS, Faculty of Dentistry, Alexandria University, Alexandria, Egypt | ||
| 2Professor of Oral Medicine, Periodontology, Oral Diagnosis and Radiology Department, Faculty of Dentistry, Alexandria University, Alexandria, Egypt. | ||
| 3Lecturer of Oral Medicine, Periodontology, Oral Diagnosis and Radiology Department, Faculty of Dentistry, Alexandria University, Alexandria, Egypt. | ||
| Abstract | ||
| INTRODUCTION: Treatment of molar furcation defects remains a considerable challenge in clinical practice. Furcation defects treatment can vary according to the type and location of the defects. Regenerative procedures are one of the treatment modalities in furcation involvement. In this study Amnion Chorion membrane(ACM) was used with an alloplast to manage grade II furcation defects. OBJECTIVES The aim of this study was to evaluate clinically and radiographically the effect of ACM augmented with alloplast bone graft in management of grade II furcation involvement. MATERIALS AND METHODS: This study was conducted clinically on fourteen patients with fourteen grade II furcation defects. Patients were divided into two groups: test group: included seven furcation defects that were treated by alloplast bone graft covered by ACM, and control group: including seven furcation defects treated with alloplast bone graft covered by a resorbable collagen membrane. Probing depth (P D), clinical attachment loss(CAL)were measured at baseline,3, and 6 months. Cone beam computed tomography(CBCT)was performed at baseline,6, and9months to evaluate bonefill in the furcation defect. RESULTS: ACM has shown reduction in probing depth and clinical attachment loss, and enhanced bone formation when compared to control group treated with resorbable collagen membrane. CONCLUSIONS: ACM is an effective, easy to handle, safe, and time saving membrane that can be used in periodontal regeneration. | ||
| Keywords | ||
| Amniotic chorion membrane; Grade II furcation defects | ||
| References | ||
|
1. Newmann MG, Takei HH, Carranza FA. Carranza's clinical periodontology.9th ed. Philadelphia: WB Saunders Co, 2002. P 67. 2. Sims T, Takei HH. Furcation involvement and treatment. In: Newman MG, Takei HH. Klokkevold PR, Carranza FA (eds). Caranza's Clinical Periodontology. 12th ed. Philadelphia: Elsevier Saunders; p 621-7. 3.American Academy of Periodontology. Parameter on occlusal traumatism in patients with chronic periodontitis. J Periodontol. 2000:71(Suppl5): 873-5. 4. Shenoy VK, Rodrigues S. Iatrogenic dentistry and the periodontium. J Indian Prosthodont Soc. 2007;7:17-20 5.Graetz C, Plaumann A, Wiebe JF, Springer C, Salzers, Dorfer CE. Periodontal probing versus radiographs for diagnosis of furcation involvement. J Periodontol 2014;85:1371-9. 6. Pradeep AR, Priyanka N, Kalra N, Naik SB, Singh SP, Martande S. Clinical efficacy of subgingivally delivered 1.2 mg simvastatin in the treatment of individuals with Class II furcation defects: a randomized controlled clinical trial. J Periodontol. 2012; 83:1472-3. 7. Jepsen S, Eberhard J, Hernera D, Needlenem T. A systematic review of guided tissue regeneration for periodontal furcation defects. What is the effect of guided tissue regeneration compared with surgical debridement in the treatment of furcation defects? J Clin Periodontol. 2002; 29(Suppl3):103-16, 160-2. 8.Gamal AY, lacono VJ. Enhancing guided tissue regeneration of periodontal defects by using a novel perforated barrier membrane. J Periodontol. 2013;84:905-13. 9. Wang HL, Cooke J. Periodontal regeneration techniques for treatment of periodontal diseases.Dent Clin North Am. 2005;49:637-59. 10.Santan RB, Leite de Mattos GM, Dyke TV. Efficacy of combined regenerative treatments in human mandibular class II furcation defects. J Periodontol. 2009;80:1756-64. 11.Gianobelle WV, Rayan S, Shih MS, Su DL, Kaplan PL, Chan TCK. Recombinant human osteogenic protein-1(OP-1) stimulates periodontal wound healing in class III furcation defects. J Periodontol. 1998;69:129-37. 12.Rosen P. A Case Report on Combination Therapy Using a Composite Allograft Containing Mesenchymal Cells With an Amnion–Chorion Barrier to Treat a Mandibular Class III Furcation. Clinical Advances in Periodontics 2013;2:64-69. 13.Gupta A, Kedige S, Jain k. Amnion and chorion membranes: potential stem cell reservoir with wide applications in periodontics. Int J Biomater 2015;2015:1-9. 14.Pakkala T, Virtanen I, Oksanen J, Jones C, Hormia M. Function of laminins and laminin binding integrins in gingival epithelial cell adhesion. J Periodontol. 2002;73:709-19. 15.Glickman I. Clinical Periodontology 4th ed. Philadelphia: WB Saunders Co; 1964. p 203-5. 16.Daniel W. Biostatistics. A foundation for analysis in the health science .6th ed. NY: John Wiley and sons, Inc; 1995. 17.Paul S, Stuart J, Cohen D. Consecutive case series using a composite allograft containing mesenchymal cells with an amnion chorion barriers to treat mandibular class III/IV furcations. IJPR 2015;35:453-60. 18.Tarnow D, Flecher P. Classification of vertical component of furcation involvement. J Periodontol. 1984; 55:283-4. 19.Glavind L, Loe H. Error in the clinical assessment of periodontal destruction. J Periodont Res. 1967;2:180 20.Ramachandran GN, Lakshminarayanan AV. Three dimensional reconstruction from radiographs and electron micrographs: Application convolutions instead of Fourier Transforms. Proc Natl Acad Sci USA. 1971;68:2236-40. 21.Kotz S, Balakrishnan N, Read CB, Vidakovic B. Encyclopedia of statistical sciences. 2nd ed. Hoboken, NJ: Wiley-Interscience; 2006. 22.Kirkpatrick LA, Feeney BC. A simple guide to IBM SPSS statistics for version 20.0. Student ed. Belmont, Calif: Wadsworth, Cengage Learning; 2013. 23.Leonhardt A, Dahlen G, Envert S. Five-year clinical, microbiological and radiological outcome following treatment of peri-implantitis in man. J Periodontol. 2003;74:1415-22. 24.Patel RA, Wilson RF, Palmer RM. The Effect of Smoking on Periodontal Bone Regeneration: A Systematic Review and Meta-Analysis. J Periodontol. 2012;83:143-55. 25.Manfredini D, Poggio CE, Lobbezoo F. Is bruxism a risk factor for dental implants? A systemic review of the literature. Clin Implant Dent Relat Res. 2012;16:460-9. 26.Dastoor SF, Travan S, Wang HL. Effect of Adjunctive Systemic Azithromycin With Periodontal Surgery in the Treatment of Chronic Periodontitis in Smokers: A Pilot Study. J Periodontol. 2007;78:1887-96. 27.Misch KA, Yi ES, Sarment DP. Accuracy of Cone Beam Computed Tomography for Periodontal Defect Measurements. J Periodontol 2006;77:1261-66. 28.Angelopoulos C, Thomas S, Hechler S, Parisis N, Hlavacek M. Comparison Between Digital Panoramic Radiography and Cone-Beam Computed Tomography for the Identification of the Mandibular Canal as Part of Presurgical Dental Implant Assessment. J Oral Maxillofac Surg. 2008;66:2130-5. 29.Holtzclaw D, Toscano N. Amnion chorion allograft barrier: Indications and techniques update. JIACD. 2012;4:25-38 30.Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S. Growthfactor m RNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000;20:173-7. 31.Shimmura S, Shimazaki J, Ohashi Y, Tsubota K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001;20:408-13. 32.Gupta I, Gupta R, Gokhale ST, Sharma A. Placental tissues: fixing smiles. Int J Innov Scientific Res 2014;7:57-62. 33. Sali DD, George JP. Demineralized Freeze Dried Bone Allograft With Amniotic Membrane in the Treatment of Periodontal Intrabony Defects - 12 Month Randomized Controlled Clinical Trial. J Periodontol. 2016;10:1-18. 34.Holtzclaw D, Hinze HF, Toscano N. Gingival flap attachment healing with amnion-chorion allograft membrane: A controlled, split mouth case report replication of the classic 1968 Hiatt Study. J Implant Adv Clin Dent 2012;4:19-25. 35.Holtzclaw DJ, Toscano NJ. Amnion–chorion allograft barrier used for guided tissue regeneration treatment of periodontal intrabony defects: A retrospective observational report. Clin Adv Periodontics 2013;3:131-7. 36.Rosen PS. A Case Report on Combination Therapy Using a Composite Allograft Containing Mesenchymal Cells With an Amnion–Chorion Barrier to Treat a Mandibular Class III Furcation. Clin Adv Periodontics. 2013;3:64-69. 37.Kumar A, Chandra RV, Reddy AA, Reddy BH, Reddy C, Naveen A. Evaluation of clinical, antiinflammatory and antiinfective properties of amniotic membrane used for guided tissue regeneration: A randomized controlled trial. Dent Res J (Isfahan). 2015; 12:127-35. 38.Kothiwale SV, Anuroopa P, Gajiwala AL. A clinical and radiological evaluation of DFDBA with amniotic membrane versus bovine derived xenograft with amniotic membrane in human periodontal grade II furcation defects. Cell Tissue Bank 2009;10:317-26. 39.In ‘t Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338–45. 40.Gomes JA, Romano A, Santos MS, Dua HS. Amniotic membrane use in ophthalmology. Curr Opin Ophthalmol. 2005;16:233-40. | ||
|
Statistics Article View: 588 PDF Download: 823 |
||
